Kura Oncology, Inc. (KURA)
NASDAQ: KURA · Real-Time Price · USD
9.01
+0.04 (0.45%)
At close: Dec 20, 2024, 4:00 PM
9.17
+0.16 (1.82%)
After-hours: Dec 20, 2024, 6:30 PM EST
Kura Oncology Stock Forecast
Stock Price Forecast
The 8 analysts with 12-month price forecasts for Kura Oncology stock have an average target of 30.13, with a low estimate of 19 and a high estimate of 37. The average target predicts an increase of 234.41% from the current stock price of 9.01.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Kura Oncology stock from 10 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 3 | 3 | 3 | 6 | 6 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 1 | 0 | 0 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 6 | 6 | 7 | 10 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Dec 9, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Nov 26, 2024 |
| B of A Securities | B of A Securities | Strong Buy Maintains $36 → $29 | Strong Buy | Maintains | $36 → $29 | +221.86% | Nov 22, 2024 |
| TD Cowen | TD Cowen | Strong Buy Reiterates n/a | Strong Buy | Reiterates | n/a | n/a | Nov 21, 2024 |
| Jefferies | Jefferies | Strong Buy Maintains $32 → $28 | Strong Buy | Maintains | $32 → $28 | +210.77% | Nov 21, 2024 |
Financial Forecast
Revenue This Year
8.67M
Revenue Next Year
17.92M
from 8.67M
Increased by 106.66%
EPS This Year
-2.11
from -2.08
EPS Next Year
-2.34
from -2.11
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 69.3M | 94.5M | 473.8M | |||
| Avg | 8.7M | 17.9M | 172.9M | |||
| Low | n/a | n/a | 7.6M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | 990.0% | 2,544.2% | |||
| Avg | - | 106.7% | 864.7% | |||
| Low | - | - | -57.3% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 1.40 | -0.66 | -1.13 | |||
| Avg | -2.11 | -2.34 | -2.29 | |||
| Low | -2.51 | -3.12 | -3.44 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.